Polyrizon Ltd. (PLRZ)

CIK 0001893645 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
FY-2025
Latest FY-2025 —
FY-2024 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
—
Audit Information
—
Statements
Balance Sheets
—
Balance Sheets (P)
—
Statements of Comprehensive Loss
—
Statements of Changes In Shareholders Equity
—
Statements of Changes In Temporary Equity and Shareholders Deficit
—
Statements of Cash Flows
—
Notes
Commitments and Contingent Liabilities
—
Convertible Notes
—
Cybersecurity Risk Management and Strategy Disclosure
—
Deferred Offering Costs
—
Derivative Warrant Liability
—
General
—
Insider Trading Policies and Procedures
—
Intangible Assets, Net
—
Investment In Shares
—
Investment In Shares and Warrants
—
Loss Per Share
—
Other Current Assets
—
Pay Vs Performance Disclosure
—
Segment Reporting
—
Selected Statements of Comprehensive Loss Data
—
Shareholders Equity
—
Significant Accounting Policies
—
Subsequent Events
—
Taxes On Income
—
Temporary Equity
—